XRad Therapeutics, Inc. — Form D

XRad Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-19. The offering totals $5.5M, of which $499K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2017-12-19
• Form: D
• Accession: 0001140361-17-046682
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $5.5M
• Amount sold: $499K
• Remaining: $5.0M
• Investors: 1
• Date of first sale: 2017-12-04
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-301137

Issuer

• Name: XRad Therapeutics, Inc.
• CIK: 0001724308
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2016
• Address: 7 ESSEX STREET #3B, NEW YORK, NY, 10002
• Phone: (917) 809-0858

Officers, directors & promoters (3)

More

• CIK 1724308 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search